UnitedHealthcare · SCS Traditional · US health-plan appeal rights

SCS Traditional denied as duplicate or overlapping therapy by UnitedHealthcare?

Q: How long do I have to appeal a UnitedHealthcare SCS Traditional denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

If two medications appear duplicative on paper but serve different clinical purposes (e.g., short-acting vs long-acting), the appeal needs to spell out the clinical rationale for both.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-10

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What UnitedHealthcare typically requires

UnitedHealthcare's specific coverage criteria for scs traditional are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: UHC Commercial: Spinal Cord and Dorsal Root Ganglion Stimulators (mirrors NACC + CMS NCD 160.7)

The UnitedHealthcare angle on SCS Traditional

## Why UnitedHealthcare Denies Traditional Spinal Cord Stimulation as Duplicate Therapy

UnitedHealthcare may issue a duplicate-therapy denial for traditional spinal cord stimulation (SCS) when it determines that another active treatment in your plan — such as an ongoing implanted device, a current neuromodulation program, or a pharmacologic pain regimen — already addresses the same clinical indication. Insurers apply this rationale to avoid authorizing two interventions they consider functionally interchangeable.

## Why This Denial Is Appealable

Duplicate-therapy denials are among the most successfully overturned on appeal because "same indication" does not mean "same mechanism, same patient response, or same clinical goal." Traditional SCS delivers continuous or high-frequency epidural electrical stimulation that works by a distinct physiological pathway. If your prescriber is recommending it alongside or instead of another modality, the medical record should explain why the prior or concurrent treatment is insufficient, contraindicated for you specifically, or addresses a different component of your pain syndrome.

## Federal Appeal Framework

You have layered federal protections regardless of whether your plan is fully insured or self-funded:

ACA §2719 / ERISA §503 internal appeal: File a written internal appeal within the deadline stated in your denial letter (typically 180 days). The plan must respond within 60 days for non-urgent requests.
External review: After exhausting internal appeal (or if the plan fails its own deadlines), you may request independent external review. The external reviewer is a board-certified specialist with no financial relationship to UHC. The ACA mandates this right for most plans; ERISA §503 enforces full-and-fair review for self-funded plans.
Expedited review: If delay would seriously jeopardize your health or ability to regain maximum function, request expedited internal and external review simultaneously — decisions are required within days, not months.
State insurance department: Fully insured plans are also subject to your state's external review law; file a complaint in parallel if the internal process stalls.

## Documentation to Gather

Diagnosis confirmation: Chart notes and imaging establishing the specific pain condition and its duration and functional impact.
Prior-treatment history: A dated list of every prior treatment tried, the duration, response, and reason for discontinuation or inadequacy — this directly rebuts the "duplicate" framing.
Clinical differentiation letter: A detailed medical-necessity letter from your implanting physician or pain specialist explaining why traditional SCS is not duplicative — specifically how it targets a different mechanism, anatomical level, or treatment goal than the cited "duplicate."
Functional severity documentation: Objective measures of functional limitation (activity logs, validated pain scales from the chart, work or daily-living impact).
Applicable guideline support: Your physician should reference the relevant professional society guideline (e.g., from the North American Neuromodulation Society or applicable pain specialty society) supporting SCS for your specific indication after failure of prior therapies.

## Criteria-Mapping Structure

Request a copy of UHC's current published coverage policy for spinal cord stimulation. List every requirement it states. For each requirement, document the exact chart fact that satisfies it — date, clinician, finding. Present this as a side-by-side table in your appeal letter. The goal is to make it impossible for a reviewer to locate an unmet criterion.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other UnitedHealthcare appeals

Other insurers on SCS Traditional

Other denial reasons for UnitedHealthcare SCS Traditional

denied as not medically necessary denied for failing step therapy denied as non-formulary denied for missing prior authorization denied as experimental or investigational

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-10. Editorial standards: denialhelp.com/authors.